Cytori Cell Research Institute, Inc.

TSE:3750 Stock Report

Market Cap: JP¥7.7b

Cytori Cell Research Institute Balance Sheet Health

Financial Health criteria checks 1/6

Cytori Cell Research Institute has a total shareholder equity of ¥2.5B and total debt of ¥2.4B, which brings its debt-to-equity ratio to 94.3%. Its total assets and total liabilities are ¥5.4B and ¥2.8B respectively.

Key information

94.3%

Debt to equity ratio

JP¥2.39b

Debt

Interest coverage ration/a
CashJP¥600.00m
EquityJP¥2.53b
Total liabilitiesJP¥2.83b
Total assetsJP¥5.37b

Recent financial health updates

No updates

Recent updates

Revenues Tell The Story For Cytori Cell Research Institute, Inc. (TSE:3750)

Apr 01
Revenues Tell The Story For Cytori Cell Research Institute, Inc. (TSE:3750)

Financial Position Analysis

Short Term Liabilities: 3750's short term assets (¥1.0B) exceed its short term liabilities (¥360.0M).

Long Term Liabilities: 3750's short term assets (¥1.0B) do not cover its long term liabilities (¥2.5B).


Debt to Equity History and Analysis

Debt Level: 3750's net debt to equity ratio (70.6%) is considered high.

Reducing Debt: 3750's debt to equity ratio has increased from 94.2% to 94.3% over the past 5 years.

Debt Coverage: 3750's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if 3750's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies